Nutex Health Q2 2024 GAAP EPS $(0.07) Beats $(0.29) Estimate, Sales $76.08M Beat $68.20M Estimate
Nutex Health Q2 2024 GAAP EPS $(0.07) Beats $(0.29) Estimate, Sales $76.08M Beat $68.20M Estimate
Nutex Health 2024财年第二季度每股收益为$(0.07)，超出预期$(0.29)，销售额为7,608万美元，超出预期6,820万美元。
Nutex Health (NASDAQ:NUTX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.29) by 75.86 percent. The company reported quarterly sales of $76.08 million which beat the analyst consensus estimate of $68.20 million by 11.55 percent. This is a 29.12 percent increase over sales of $58.92 million the same period last year.
Nutex Health (纳斯达克股票代码：NUTX)报告每股亏损$(0.07)，超过分析师共识预期$(0.29)的75.86%。该公司报告季度销售额为7608万美元，超过分析师共识预期6820万美元，增长11.55%。这比去年同期的销售额5892万美元增长了29.12％。